Role of epidermal growth factor receptor in acute and chronic kidney injury.
about
EGFR signaling in renal fibrosisEpigenetics in acute kidney injuryTargeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond.Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.Class I HDAC activity is required for renal protection and regeneration after acute kidney injuryRenal cortical hexokinase and pentose phosphate pathway activation through the EGFR/Akt signaling pathway in endotoxin-induced acute kidney injury.To cleave or not to cleave: role of ADAM17 in cell proliferation in PKD.Protein-bound uremic toxins induce tissue remodeling by targeting the EGF receptorEpidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in ratsComparison of biomarkers in rat renal ischemia-reperfusion injury.IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease.EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.Interaction of the EGF Receptor and the Hippo Pathway in the Diabetic Kidney.Epidermal growth factors in the kidney and relationship to hypertension.Class I histone deacetylase activity is required for proliferation of renal epithelial cells.ADAM17 substrate release in proximal tubule drives kidney fibrosisRenoprotective approaches and strategies in acute kidney injuryThe Role of Tyrosine Kinase Receptors in Peritoneal FibrosisThe epidermal growth factor receptor pathway in chronic kidney diseases.Mitochondrial Pathology and Glycolytic Shift during Proximal Tubule Atrophy after Ischemic AKI.Role of TGF-alpha in the progression of diabetic kidney disease.Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis.EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption.Can we fight chronic kidney disease by targeting endothelial HB-EGF?Urinary excretion of EGF and MCP-1 in children with vesicoureteral reflux.Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters.EGF regulation of proximal tubule cell proliferation and VEGF-A secretion.Epidermal growth factor as a prognostic biomarker in chronic kidney diseases.Therapeutic effects of histone deacetylase inhibitors on kidney disease.Renal fibrosis: Primacy of the proximal tubule.Blood HER2 and Uromodulin as Causal Mediators of CKD.Depletion of Gprc5a Promotes Development of Diabetic Nephropathy.Modulation of Sox10, HIF-1α, Survivin, and YAP by Minocycline in the Treatment of Neurodevelopmental Handicaps following Hypoxic Insult.IL-22 sustains epithelial integrity in progressive kidney remodeling and fibrosisJagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming
P2860
Q26796628-E1607209-9028-49BF-A9D3-5A2E43D7FB62Q28080924-51EA6886-3C8C-4367-B159-A28BDBE7DF2EQ33620537-FE3208B3-C125-4E23-A374-BE3237E9B7DDQ33872509-B79E257E-9D49-4370-A017-13AA221A5FC7Q34001310-7C1AB98A-6734-48B0-A7D2-84E14559EA6DQ34062861-33B40715-A5C5-4C47-B977-817AB0201822Q34200977-5A61607D-5F71-45D0-B760-9E6175D9EC11Q35027277-4CD2B3EB-F889-4248-A78F-64A53219FC8DQ35413351-B717BBAC-8481-4D69-B127-ADCE4659DFBEQ35870852-2DEC71D6-0B75-4ABD-B3B4-24EDD83CE225Q36040523-24E18373-825B-49A3-A24B-535C415C1250Q36223297-C763C0F7-7044-41DE-A909-E58DC71FAA3AQ36777632-7638545F-0217-46AB-B062-582AA3960E23Q36944680-03BC6ACC-2E58-46FA-A3C5-0643D7684396Q37051477-F8D51A69-BCA0-43B0-B870-8FF0C5832275Q37093664-2FDFFACD-C93A-4CC5-94BD-0D33E925523DQ37262336-EF520806-8FEE-4B8F-BC9C-35C2EC9A82F8Q37441818-C9E0C977-23D9-4C52-9F4B-FDD9C755C9CBQ38602815-C7ED160C-16B1-4EFD-BE9A-332878F13C9DQ38885079-BD662F54-FE8B-4575-9773-BA97596B547DQ39901297-F3EB1085-1410-4006-A39C-E3C3D9713E72Q40312801-5EC32038-116D-46A3-ADB1-1004FDA1442EQ40974170-B6BFF881-07E6-4F61-9EAC-F0853E4E2023Q41645505-ACBBAC10-D4F6-4E31-8814-E23F6DB9440DQ41776022-265F7EF7-09F5-49E0-906B-FB4D87466F59Q41807194-2BC69CB8-24CC-457C-87EC-19819DFF3C63Q41878918-2A365F51-696D-4531-88FC-7C4550DACB76Q42093775-C89A1D42-F01C-477D-98A9-E3839749317EQ42106829-CF6AFECF-7053-4DB4-89F2-4960297F4B2EQ48136812-8F2DF868-1305-4781-BFCA-15C0D0722D78Q50097164-E0486BBD-027E-434C-83CA-9A7581DF29C4Q51743726-1C8551FD-E54B-4114-AA66-B47D225CF0BDQ52595469-FD659D6D-E5D4-487F-AA8D-D2637F39BAC1Q55162469-86E07819-EE96-4AC4-B4FE-5D901858218BQ58699771-1547CA3B-06FD-4018-B728-5C1E5B9B6ACAQ58723519-EDC10AA8-697A-4544-AD5F-72543E554D10
P2860
Role of epidermal growth factor receptor in acute and chronic kidney injury.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Role of epidermal growth factor receptor in acute and chronic kidney injury.
@ast
Role of epidermal growth factor receptor in acute and chronic kidney injury.
@en
type
label
Role of epidermal growth factor receptor in acute and chronic kidney injury.
@ast
Role of epidermal growth factor receptor in acute and chronic kidney injury.
@en
prefLabel
Role of epidermal growth factor receptor in acute and chronic kidney injury.
@ast
Role of epidermal growth factor receptor in acute and chronic kidney injury.
@en
P2093
P2860
P921
P356
P1433
P1476
Role of epidermal growth factor receptor in acute and chronic kidney injury.
@en
P2093
Jinhua Tang
Shougang Zhuang
P2860
P2888
P304
P356
10.1038/KI.2012.435
P407
P577
2013-01-16T00:00:00Z
2013-05-01T00:00:00Z